MCKINLEY JONES: Open Payments
NPI 1164095915 · HANCEVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$290 in 15 payments from 10 companies in 2025. Trend: 2023 $72 · 2024 $275 · 2025 $290
Food & beverage: $290
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $58 |
| Amgen Inc. | 2 | $45 |
| Lilly USA, LLC | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
| Exact Sciences Corporation | 1 | $21 |
| Gilead Sciences, Inc. | 1 | $18 |
| PFIZER INC. | 1 | $16 |
| ABBVIE INC. | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $12 |
Products named: Ozempic, ZEPBOUND, CAPLYTA, Kerendia, REPATHA, OTEZLA, The Cologuard Plus Collection Kit, Wegovy.
Industry payments across AL — which companies pay providers there.
